CONMED CORPORATION (CNMD) Operating Margin
- Operating margin · 12 months: Value 8.04%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 8.04% | Operating income / revenue. Period ending 2026-06-30. $110.32M ÷ $1.37B × 100 ≈ 8.04% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 110.32M USD | Operating Income (Loss) |
| Revenue | 1.37B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 606.35M USD | Cost of Goods and Services Sold |
| Research and development | 60.63M USD | Research and Development Expense |
| Selling, general and administration | 594.35M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110.32M | $1.37B | $606.35M | $60.63M | $594.35M | 8.04% |
| 2025-12-31 | $102.62M | $1.37B | $624.25M | $55.88M | $591.97M | 7.46% |
| 2025-09-30 | $118.50M | $1.35B | $616.94M | $54.16M | $557.88M | 8.79% |
| 2025-06-30 | $172.32M | $1.33B | $582.84M | $53.82M | $517.27M | 12.99% |
| 2025-03-31 | $181.27M | $1.32B | $577.18M | $53.78M | $503.77M | 13.77% |
| 2024-12-31 | $200.33M | $1.31B | $573.98M | $54.43M | $478.28M | 15.33% |
| 2024-09-30 | $198.01M | $1.29B | $571.25M | $55.28M | $463.57M | 15.37% |
| 2024-06-30 | $162.61M | $1.28B | $570.07M | $54.18M | $489.14M | 12.74% |
| 2024-03-31 | $142.92M | $1.26B | $568.66M | $53.66M | $496.31M | 11.33% |
| 2023-12-31 | $120.60M | $1.24B | $568.50M | $52.60M | $503.04M | 9.69% |
| 2023-09-30 | $69.32M | $1.17B | $542.63M | $50.79M | $505.82M | 5.93% |
| 2023-06-30 | $63.27M | $1.14B | $529.59M | $51.10M | $495.12M | 5.55% |
| 2023-03-31 | $60.31M | $1.10B | $508.04M | $49.02M | $481.25M | 5.49% |
| 2022-12-31 | $70.05M | $1.05B | $474.23M | $47.15M | $454.04M | 6.70% |
| 2022-09-30 | $108.36M | $1.07B | $473.34M | $46.29M | $440.58M | 10.14% |
| 2022-06-30 | $110.83M | $1.04B | $456.38M | $44.39M | $430.72M | 10.63% |
| 2022-03-31 | $112.08M | $1.02B | $444.71M | $44.21M | $419.29M | 10.99% |
| 2021-12-31 | $109.72M | $1.01B | $442.60M | $43.56M | $414.75M | 10.86% |
| 2021-09-30 | $97.20M | $989.49M | $441.80M | $43.92M | $406.57M | 9.82% |
| 2021-06-30 | $99.87M | $978.50M | $439.42M | $43.00M | $396.21M | 10.21% |
| 2021-03-31 | $52.92M | $881.13M | $411.54M | $40.38M | $376.29M | 6.01% |
| 2020-12-31 | $46.01M | $862.46M | $402.16M | $40.47M | $373.82M | 5.33% |
| 2020-09-30 | $49.19M | $874.50M | $407.74M | $40.85M | $376.72M | 5.62% |
| 2020-06-30 | $40.74M | $870.25M | $407.08M | $41.90M | $380.53M | 4.68% |
| 2020-03-31 | $80.65M | $950.73M | $428.29M | $45.01M | $396.78M | 8.48% |
| 2019-12-31 | $79.11M | $955.10M | $430.38M | $45.46M | $400.14M | 8.28% |
| 2019-09-30 | $77.06M | $932.67M | $417.28M | $43.74M | $394.60M | 8.26% |
| 2019-06-30 | $67.64M | $901.39M | $405.48M | $46.87M | $381.40M | 7.50% |
| 2019-03-31 | $65.66M | $875.95M | $394.96M | $45.05M | $370.27M | 7.50% |
| 2018-12-31 | $71.31M | $859.63M | $390.52M | $42.19M | $355.62M | 8.29% |
| 2018-09-30 | $68.66M | $839.75M | $379.33M | $40.20M | $351.56M | 8.18% |
| 2018-06-30 | $70.61M | $827.56M | $375.22M | $34.34M | $347.38M | 8.53% |
| 2018-03-31 | $66.71M | $811.89M | $371.18M | $32.40M | $341.61M | 8.22% |
| 2017-12-31 | $46.94M | $796.39M | $365.35M | $32.31M | $351.80M | 5.89% |
| 2017-09-30 | $36.37M | $777.93M | $363.89M | $31.56M | $346.12M | 4.67% |
| 2017-06-30 | $36.74M | $772.61M | $359.90M | $31.65M | $344.32M | 4.76% |
| 2017-03-31 | $31.64M | $768.89M | $358.41M | $31.61M | $347.22M | 4.12% |
| 2016-12-31 | $37.68M | $763.52M | $355.19M | $32.25M | $338.40M | 4.93% |
| 2016-09-30 | $38.04M | $750.44M | $346.70M | $31.36M | $334.35M | 5.07% |
| 2016-06-30 | $39.03M | $734.84M | $338.75M | $29.66M | $327.40M | 5.31% |
| 2016-03-31 | $43.76M | $722.43M | $335.27M | $29.15M | $314.25M | 6.06% |
| 2015-12-31 | $51.17M | $719.17M | $337.47M | $27.44M | $303.09M | 7.12% |
| 2015-09-30 | $55.30M | $723.15M | $339.80M | $27.80M | $270.71M | 7.65% |
| 2015-06-30 | $42.91M | $728.93M | $342.70M | $28.06M | $285.71M | 5.89% |
| 2015-03-31 | $46.43M | $736.05M | $342.30M | $27.41M | $290.36M | 6.31% |
| 2014-12-31 | $52.79M | $740.05M | $336.00M | $27.78M | $293.94M | 7.13% |
| 2014-09-30 | $51.88M | $748.49M | $337.07M | $27.11M | $301.44M | 6.93% |
| 2014-06-30 | $58.23M | $752.79M | $342.36M | $27.31M | $303.68M | 7.74% |
| 2014-03-31 | $57.95M | $757.63M | $345.31M | $27.05M | $306.82M | 7.65% |
| 2013-12-31 | $56.51M | $762.70M | $350.29M | $25.83M | $310.73M | 7.41% |
| 2013-09-30 | $57.34M | $760.51M | $352.20M | $26.24M | $308.27M | 7.54% |
| 2013-06-30 | $62.65M | $763.14M | $352.34M | $26.21M | $308.86M | 8.21% |
| 2013-03-31 | $64.06M | $759.84M | $352.22M | $26.81M | $305.39M | 8.43% |
| 2012-12-31 | $65.21M | $767.14M | $361.30M | $28.21M | $302.47M | 8.50% |
| 2012-09-30 | $6.57M | $751.47M | $356.46M | $28.52M | $292.90M | 0.87% |
| 2012-06-30 | $8.39M | $742.40M | $354.00M | $28.46M | $287.19M | 1.13% |
| 2012-03-31 | $8.03M | $735.94M | $355.81M | $28.07M | $281.34M | 1.09% |
| 2011-12-31 | $8.27M | $725.08M | $350.14M | $28.65M | $276.62M | 1.14% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $720.81M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $57.09M | $713.72M | $348.34M | $29.65M | $276.46M | 8.00% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $28.27M | $694.74M | $357.41M | $31.84M | $266.31M | 4.07% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |